When the usual remedies fail, injured workers are increasingly turning to cannabis for relief. A recent study from Ontario reveals that individuals managing work-related injuries are incorporating cannabis into their recovery journeys in ways that are both intricate and largely self-guided.
But here's where it gets controversial: This isn't about recreational use; it's about finding solace when conventional treatments just don't cut it. The research, spearheaded by Dr. Nancy Carnide from the Institute for Work & Health (IWH), delves into the experiences of 45 Ontario workers who found themselves using cannabis to cope with persistent pain, sleepless nights, and overwhelming stress stemming from their injuries.
These individuals, initially identified in a previous survey of workers with accepted lost-time compensation claims, were revisited four to five years after their initial injury. This longitudinal approach offers a profound glimpse into the long-term impact of work injuries and the evolving strategies workers employ.
Cannabis: A "Pragmatic Option" in the Wake of Workplace Injuries
In an earlier survey, a notable 14 percent of injured workers admitted to using cannabis to manage their work-related conditions. These individuals, compared to their peers who either didn't use cannabis or used it for non-injury related reasons, were more likely to report experiencing higher levels of pain, significant sleep disturbances, poorer mental health outcomes, and were less likely to be back at work. What's particularly striking is that the majority of these workers were self-medicating without any guidance from a healthcare professional.
The follow-up interviews were designed to unearth the deeper narratives. Dr. Carnide explains, "Cannabis often became a pragmatic option for treatment when other approaches fell short." She emphasizes that it was seldom the first port of call. Participants typically exhausted options like over-the-counter and prescription medications, alongside therapies such as physiotherapy, massage, and chiropractic care. However, many found these conventional methods to be limited in their effectiveness, accompanied by difficult side effects, fueled concerns about opioid reliance, or presented cost barriers that made ongoing physical therapies unsustainable.
Furthermore, workers recounted prolonged and complicated recovery processes. Years after their initial injury, many still grappled with lingering symptoms, sometimes compounded by a history of multiple past injuries. Some faced delays in accessing necessary surgeries, felt pressured to return to work prematurely despite ongoing pain, encountered challenging interactions with the compensation system, and received accommodations that were either short-lived or ill-suited to their needs.
Symptom Relief, But Not a Miracle Cure
The majority of participants reported experiencing at least some positive effects from their cannabis use. These benefits were primarily focused on symptom management: relief from pain, improved sleep quality, a reduction in muscle tension or spasms, and for some, a calming effect on anxiety and stress. The impact on their ability to work was generally indirect, with workers describing cannabis as a tool that helped them achieve sufficient rest to function the following day or to better tolerate residual pain during their shifts.
Dr. Carnide notes that interviewees rarely viewed cannabis as a solution for the underlying injury itself. Instead, it was perceived as "more of a coping tool – one part of a broader toolbox rather than a cure," used in conjunction with other medications, physical therapies, and self-management techniques. A segment of workers even reported that cannabis helped them reduce their dependence on other medications or made it easier to engage in rehabilitation activities by making their symptoms more manageable.
And this is the part most people miss: Not all experiences were positive. Some workers reported functional drawbacks, including decreased motivation, difficulty concentrating, and a pervasive sense of "brain fog." A small number expressed concerns that their cannabis use was becoming habitual rather than strictly focused on injury-related needs. Many embarked on a journey of trial and error, experimenting with different products, strains, dosages, and methods of consumption. For some, this process led to unpleasant experiences or ultimately failed to yield a workable regimen.
Dr. Carnide clarifies that the study's aim was not to establish definitive effectiveness. "We cannot say that cannabis is an effective option for injured workers…what it does show is that workers are using cannabis and self-reporting benefits across a range of injuries and symptom profiles," she states, adding that this includes conditions for which the general scientific literature has not yet established strong evidence for cannabis efficacy.
Private Use, Hesitant Disclosure, and Policy Gaps in the Workplace
A significant aspect of the study explored how workers navigated their cannabis use in the context of their employment. Many participants described implementing personal strategies to balance symptom management with perceived workplace safety expectations and policies. Common approaches included limiting cannabis use to evenings or bedtime to ensure a clear separation from work hours, or opting for products believed to be less impairing, such as CBD-dominant or topical formulations, when use occurred closer to work time.
Formal workplace accommodations for medical cannabis use were largely absent among the study participants. Dr. Carnide observed that cannabis use was "often managed privately, without formal workplace processes to support it," and that a widespread hesitancy to disclose use was evident. Workers cited reasons such as stigma, fears of being perceived as perpetually impaired, and concerns that any workplace incident would be automatically attributed to cannabis use, regardless of their actual state of impairment at the time.
These findings carry significant implications for employers and occupational health professionals. Dr. Carnide advocates for the necessity of clear, well-communicated workplace substance-use policies that specifically address medically used products that may cause impairment. Furthermore, she stresses the importance of establishing safe disclosure channels that reduce the incentive for concealment and promote proactive risk management.
What do you think? Is it time for workplaces to develop more comprehensive policies around medical cannabis use, or are the potential risks too great? Share your thoughts in the comments below!
